FindTrial
Sign In

A safety epidemiological study assessing the effect of Daikenchuto (TJ-100) on the risk of liver injury in cancer patients who underwent colectomy or gastrectomy

A safety epidemiological study assessing the effect of Daikenchuto (TJ-100) on the risk of liver injury in cancer patients who underwent colectomy or gastrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1031240102
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-05-22
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stomach cancer

Interventions

None listed

Sponsors

asakawa takeshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Colon cancer patients who underwent colon surgery and gastric cancer patients who underwent gastrectomy between April 2008 and May 2019

Exclusion criteria

Exclusion criteria: Patients who meet the following criteria will be excluded. Cancer patients who underwent complex surgery Patients who underwent hepatectomy Patients diagnosed with liver comorbidities before surgery Patients who were prescribed choleretic agents or hepatoprotective drugs before surgery Patients prescribed antibiotics before surgery Patients prescribed anti-tumor drugs before surgery Patients who received blood transfusion on the day before surgery

Design outcomes

Primary

MeasureTime frame
Whether there is a record of being prescribed choleretic agents or liver-protecting drugs—

Secondary

MeasureTime frame
Whether there is a record of being prescribed a choleretic agent or a liver-protecting drug and a steroid preparation.—

Contacts

Public Contactyuu wada

TSUMURA & CO.

tsu_jp_rd_ds01@mail.tsumura.co.jp+81-29-889-3862

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026